In South-Eastern Europe, and Western and Central Europe, amphetamine-type stimulants (ATS) use and health harm remain mainly linked to amphetamine and are relatively low compared to other regions.Amphetamines are the third most common stimulant drugs group in Europe after cocaine and “ecstasy”.…
Methamphetamine and other ATS remain the leading substances for which people seek drug treatment in East and South-East Asia.The number of people receiving treatment for ATS use, mainly methamphetamine, has remained stable or declined in the majority of reporting countries – with the exception of…
Cannabis use has risen over the past 20 years in South and Central America but is showing signs of stabilizationSouth and Central America account for around 30 per cent of global cannabis herb seizures quantity. Over the past 20 years, use among the general population aged 15-64 has increased –…
Limited data suggest that cannabis use in Africa is higher than the global average, with large differences between women and men.Limited data suggest that cannabis use in Africa is higher among the general population aged 15-64 than the global average – driven by relatively high prevalence among…
The non-medical use of cannabis in Australia has remained broadly stable, while trends in New Zealand have levelled off after earlier growth.In Australia, cannabis use has remained relatively stable over the past 2 decades. However, between 2019 and 2022/23 cannabis use increased among women (…
Cannabis use in Europe stabilizes after long-term growth.Cannabis remains the most widely used drug in Europe, with an estimated 31 million users in 2024 (10 million women and 21 million men).In the majority of countries with available data, use has stabilized in recent years following long-term…
The use of amphetamines has distinct regional patterns; past-year use is generally higher among men (0.85 per cent) than women (0.34 per cent) globally.The largest markets for ATS, mainly methamphetamine, remain East and South-East Asia and North America. The highest past-year use of amphetamines…
“Ecstasy” use remains highest in high income countries and parts of Asia.Past-year use of "ecstasy" globally is estimated at 0.4 per cent among those aged 15-64. Use is higher among men (0.54 per cent) than women (0.26 per cent), but the difference is not as pronounced as for other drugs (for…
Australia and New Zealand have the highest global annual prevalence of use of "ecstasy", where it is mostly used in capsule and crystal form.In Australia, the use and availability of "ecstasy" declined during the COVID-19 pandemic but have started to increase again in 2023 (while not yet reaching…
“Ecstasy” use remains concentrated in Europe (mainly Western and Central Europe)Use is significantly higher in Western and Central Europe than in Eastern and South-Eastern Europe, both in terms of prevalence (1.2 per cent vs. 0.4 per cent) and number of users (nearly 4 million versus less than 800,…
Cannabis use remains widespread globally, with steady long-term growth.Prevalence of past-year cannabis use is highest in North America, Australia and New Zealand, and West and Central Africa, while North America and South Asia have the highest number of people who use cannabis.Cannabis use has…
As intensive methamphetamine use has increased in both Australia and New Zealand, associated health harms have also increased.In Australia, hospitalizations and the number of people in drug-related treatment related to methamphetamine use have increased over the long-term, although recent data…
